Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joost G. E
Hospital-based innovation labs to accelerate digital health transformation: lessons learned from twenty types of experts - BMC Digital Health
Abstract The digital transformation of healthcare is often hindered by various legal, ethical, financial, technological, and other barriers. Often, organizations already contain the expert knowledge needed to help innovators with these challenges, but highly fragmented. In an attempt to centralize this support, many major healthcare centers have established some form of innovation center or lab.
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and over - Netherlands Heart Journal
Abstract Cardiovascular disease and frailty are common among the population aged 85+. We hypothesised these patients might benefit from geriatric co-management, as has been shown in other frail patient populations. However, there is limited evidence supporting geriatric co-management in older, hospitalised cardiology patients. A retrospective cohort study was performed in a large teaching hospital in the Netherlands.
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation
BMC Cancer, Jan 2023 This is a preview of a remote PDF: https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-10412-x Verbeek, Joost G. E., de Jong, Vincent M. T., Wijnja, Hanna M., Jager, Agnes, Linn, Sabine C., Retèl, Valesca P., van Harten, Wim H.. , BMC Cancer, 2023, pp. 1-11, Volume 23, Issue 1, DOI: 10.1186/s12885-022-10412-x
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation - BMC Cancer
Characteristics of participants We conducted in-depth semi-structured interviews with 28 stakeholders between June 2019 and April 2021. The interviewees were eight medical oncologists, two specialized oncology nurse practitioners, three research nurses, one hematologist, one hospital pharmacist, three patients, two patient representatives, three scientists, and five policy-makers. They had an average age of 47 years (range: 30–73) and all but one policy-maker noted to be knowledgeable about HDCT.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joost G.
Contact Joost G., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack